2003Diabetologia CroaticaRequires access

Obesity – risk factor for microvascuar and neuropatic complication in diabetes?

Martina Tomić, Tamara Poljičanin, Ivana Pavlić-Renar, Željko Metelko

Open publisher page 8 citations

Abstract

The aim of the study was to investigate whether obestiy, independently or associated with other risk factors, increases the risk for the diabetic retinopathy, nephropathy and neuropathy in type 2 diabetic persons. Data of 156 diabetic persons that have consecutively attended the Outpatient Department during two months period were studied. According to their body mass index (BMI) they were divided into three groups: group 1 (BMI  25 ; n=49), group 2 (BMI 26-29, 9 ; n=52) and group 3 (BMI  30 ; n=55). The three groups did not differ in age, duration of diabetes, treatment, cholesterol, HDL-cholesterol and triglycerides. With increase in BMI, we observed a significant deterioration of HbA1c and a significant increase in LDL-cholesterol, systolic and diastolic blood pressure. The prevalence of retinopathy increased significantly with higher body weight (p<0, 05), but also with correlation to quality of metabolic control (HbA1c) and systolic blood pressure. The increase of the prevalence of nephropathy and polyneuropathy was significantly and independantly related to the body weight (p<0, 01). Therefore, obesity is, independantly or in correlation to quality of metabolic control (HbA1c), systolic and diastolic blood pressure and LDL-cholesterol, risk factors for microvascular and neuropathic complications in diabetes.

About this research paper

What this paper is about

The aim of the study was to investigate whether obestiy, independently or associated with other risk factors, increases the risk for the diabetic retinopathy, nephropathy and neuropathy in type 2 diabetic persons. Data of 156 diabetic persons that have consecutively attended the Outpatient Department during two months period were studied. According to their body mass index (BMI) they were divided into three groups: group 1 (BMI  25 ; n=49), group 2 (BMI 26-29, 9 ; n=52) and group 3 (BMI  30 ; n=55). The three groups did not differ in age, duration of diabetes, treatment, cholesterol, HDL-cholesterol and triglycerides. With increase in BMI, we observed a significant deterioration of HbA1c and a significant increase in LDL-cholesterol, systolic and diastolic blood pressure. The prevalence of retinopathy increased significantly with higher body weight (p<0, 05), but also with correlation to quality of metabolic control (HbA1c) and systolic blood pressure. The increase of the prevalence of nephropathy and polyneuropathy was significantly and independantly related to the body weight (p<0, 01). Therefore, obesity is, independantly or in correlation to quality of metabolic control (HbA1c), systolic and diastolic blood pressure and LDL-cholesterol, risk factors for microvascular and neuropathic complications in diabetes.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The aim of the study was to investigate whether obestiy, independently or associated with other risk factors, increases the risk for the diabetic retinopathy, nephropathy and neuropathy in type 2 diabetic persons. Data of 156 diabetic persons that have consecutively attended the Outpatient Department during two months period were studied. According to their body mass index (BMI) they were divided into three groups: group 1 (BMI  25 ; n=49), group 2 (BMI 26-29, 9 ; n=52) and group 3 (BMI  30 ; n=55). The three groups did not differ in age, duration of diabetes, treatment, cholesterol, HDL-cholesterol and triglycerides. With increase in BMI, we observed a significant deterioration of HbA1c and a significant increase in LDL-cholesterol, systolic and diastolic blood pressure. The prevalence of retinopathy increased significantly with higher body weight (p<0, 05), but also with correlation to quality of metabolic control (HbA1c) and systolic blood pressure. The increase of the prevalence of nephropathy and polyneuropathy was significantly and independantly related to the body weight (p<0, 01). Therefore, obesity is, independantly or in correlation to quality of metabolic control (HbA1c), systolic and diastolic blood pressure and LDL-cholesterol, risk factors for microvascular and neuropathic complications in diabetes.

Key concepts: Medicine, Blood pressure, Body mass index, Diabetes mellitus, Internal medicine, Retinopathy, Risk factor, Obesity

Related papers

Back to paper searchBrowse research topicsOriginal source
Obesity – risk factor for microvascuar and neuropatic complication in diabetes? — Research Paper | ScholarLens